[go: up one dir, main page]

BE905516A - NEW EXTENDED RELEASE FORMULATION. - Google Patents

NEW EXTENDED RELEASE FORMULATION.

Info

Publication number
BE905516A
BE905516A BE1/011554A BE1011554A BE905516A BE 905516 A BE905516 A BE 905516A BE 1/011554 A BE1/011554 A BE 1/011554A BE 1011554 A BE1011554 A BE 1011554A BE 905516 A BE905516 A BE 905516A
Authority
BE
Belgium
Prior art keywords
release formulation
extended release
new extended
pharmaceutically acceptable
substance
Prior art date
Application number
BE1/011554A
Other languages
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE905516A publication Critical patent/BE905516A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Formulation à libération prolongée pour l'administration par voie orale, comprenant une substance choisie parmi le pindolol et un ester de l'acide 4- (2,1,3-benzoxadiazole-4-yl) -1,4-dihydroxy-2,6- diméthyl-pyridine -3,5-dicarboxylique, une substance gonflante hydrophile pharmaceutiquement acceptable et éventuellement une matière grasse inerte pharmaceutiquement acceptable.Sustained-release formulation for oral administration, comprising a substance chosen from pindolol and an ester of 4- (2,1,3-benzoxadiazole-4-yl) -1,4-dihydroxy-2 acid, 6-dimethyl-pyridine -3,5-dicarboxylic, a pharmaceutically acceptable hydrophilic swelling substance and optionally a pharmaceutically acceptable inert fat.

BE1/011554A 1985-10-01 1986-09-30 NEW EXTENDED RELEASE FORMULATION. BE905516A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BE905516A true BE905516A (en) 1987-03-30

Family

ID=27516617

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011554A BE905516A (en) 1985-10-01 1986-09-30 NEW EXTENDED RELEASE FORMULATION.

Country Status (20)

Country Link
KR (1) KR920008817B1 (en)
AT (1) AT402257B (en)
BE (1) BE905516A (en)
CA (1) CA1298784C (en)
CH (1) CH669524A5 (en)
DE (1) DE3632201C2 (en)
DK (1) DK170016B1 (en)
ES (1) ES2002508A6 (en)
FR (1) FR2589732B1 (en)
GR (1) GR862457B (en)
HK (1) HK392A (en)
HU (1) HU197201B (en)
IE (1) IE59589B1 (en)
IL (1) IL80182A (en)
LU (1) LU86615A1 (en)
NL (1) NL194822C (en)
NZ (1) NZ217732A (en)
PT (1) PT83456B (en)
SE (1) SE503222C2 (en)
SG (1) SG103391G (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
DE60229123D1 (en) * 2001-02-20 2008-11-13 Dinan Timothy Gerard TREATMENT OF FIBROMYALGIA WITH PINDOLOL
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
CH639659A5 (en) * 1978-12-18 1983-11-30 Sandoz Ag NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
DD145004A3 (en) * 1978-09-25 1980-11-19 Reinhard Huettenrauch METHOD FOR PRODUCING SOLID A NOMENCLATES
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (en) * 1980-05-21 1985-12-09 塩野義製薬株式会社 sustained release formulation
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
JPS61501511A (en) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション sustained release pharmaceutical capsules
JPS6124516A (en) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd Long active tablet

Also Published As

Publication number Publication date
IL80182A (en) 1991-01-31
GR862457B (en) 1987-01-29
NL8602370A (en) 1987-05-04
IL80182A0 (en) 1986-12-31
NL194822B (en) 2002-12-02
PT83456A (en) 1986-10-01
ES2002508A6 (en) 1988-08-16
HU197201B (en) 1989-03-28
IE862565L (en) 1987-04-01
SG103391G (en) 1992-01-17
PT83456B (en) 1989-05-12
ATA260486A (en) 1996-08-15
KR870003777A (en) 1987-05-04
DE3632201A1 (en) 1987-04-02
KR920008817B1 (en) 1992-10-09
FR2589732A1 (en) 1987-05-15
DE3632201C2 (en) 1997-05-07
DK170016B1 (en) 1995-05-01
AT402257B (en) 1997-03-25
NL194822C (en) 2003-04-03
IE59589B1 (en) 1994-03-09
DK464686A (en) 1987-04-02
HK392A (en) 1992-01-10
SE503222C2 (en) 1996-04-22
CA1298784C (en) 1992-04-14
CH669524A5 (en) 1989-03-31
SE8604112D0 (en) 1986-09-29
LU86615A1 (en) 1987-04-02
NZ217732A (en) 1990-07-26
DK464686D0 (en) 1986-09-29
HUT44701A (en) 1988-04-28
FR2589732B1 (en) 1989-07-13
SE8604112L (en) 1987-04-02

Similar Documents

Publication Publication Date Title
OA09415A (en) "Pharmaceutical composition for oral administration based on a derivative of diphosphonic acid".
ATE41739T1 (en) SOLID ORAL DOSAGE FORMULATIONS OF CONSTANT RELEASE RATE CARDIOVASCULAR AGENTS.
ATA189395A (en) ORAL PHARMACEUTICAL PREPARATION
FR2613224B1 (en) EXTENDED RELEASE BILAYER DOSAGE FORM
IT1200178B (en) GALENIC FORMULATIONS WITH SCHEDULED SALE CONTAINING DRUGS WITH ANTI-FLOGISTIC ACTIVITY
DK0610595T3 (en) Composition of L-DOPA Esters
IL96900A0 (en) Pharmaceutical composition containing naproxen
KR900012911A (en) Excitatory Amino Acid Receptor Antagonist Compound
NO883667D0 (en) Capsule for pharmaceutically active ingredients of a drug.
FR2321892A1 (en) PHARMACEUTICAL PREPARATIONS FOR ORAL ADMINISTRATION CONTAINING NANDROLONE-17B ESTER AND NEW NANDROLONE-17B ESTERS
FR2688405B1 (en) PROCESS FOR THE PREPARATION OF A STABLE MEDICINAL SOLUTION FOR ORAL CONTROLLED RELEASE, BASED ON A BETA-BLOCKER, AND PHARMACEUTICAL COMPOSITION BASED ON A BETA-BLOCKER.
BE905516A (en) NEW EXTENDED RELEASE FORMULATION.
BE903029A (en) NEW PHARMACEUTICAL FORMS ADMINISTRABLE BY NASAL.
KR890701087A (en) Formulation for oral administration of buspirone and its salts
BE1002182A5 (en) PHARMACEUTICAL COMPOSITIONS.
BE904152A (en) SUSTAINED RELEASE FORMULATION CONTAINING Rye ergot alkaloids.
BE877703A (en) PHARMACEUTICAL COMPOSITIONS BASED ON TRIMETHOPRIM AND N-ETHYL- -PYRIDONE-3-CARBOXYLIC ACID DERIVATIVES
BE901810A (en) BROMOCRIPTINE COMPOSITIONS.
FR2598618B1 (en) PHARMACEUTICAL COMPOSITION FOR IMPROVING BLOOD LIPID CONSTITUTION
BE880648A (en) NOVEL GALENIC FORMS OF ORAL DRUG DELIVERY, SCHEDULED RELEASE AND PREPARATION METHODS
FR2444462A1 (en) COMPOSITIONS FOR CONTROLLING HYPERTENSION AND INTESTINAL DISORDERS COMPRISING AN N-ARYL N'2- (IMIDAZOLIDINYLIDENE) -URA DERIVATIVE
FR2602680B1 (en) PHARMACEUTICAL COMPOSITIONS FOR NASAL ADMINISTRATION
OA09471A (en) "Novel substituted benzothiazolinones, their preparation process and pharmaceutical compositions which contain them".
KR860002498A (en) Pharmaceutical Compositions of 1,4-Dihydropyridine Derivatives

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *NOVARTIS A.G.

Effective date: 20060930